← All organizations

Citius Pharmaceuticals

For profitWebsite ↗

Also known as: Citius Pharmaceuticals | Citius Pharmaceuticals, Inc. | CITIUS PHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Aug 7, 2024

Defunct as of Oct 1, 2019

Timeline

2000s

Jan 1, 2007
Citius Pharmaceuticals— Founded

2010s

Jun 13, 2011
phentermine— NDA Secondary Org
Apr 4, 2016
Leonard-Meron Biosciences, Inc.— Acquired
Oct 1, 2019
Citius Pharmaceuticals— Defunct

2020s

Aug 7, 2024
denileukin diftitox— Marketing Organization

Drugs by trial phase (6 distinct, 3 trials)

Phase 3 (0 own, 3 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Hemorrhoids

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Leonard-Meron Biosciences, Inc.

Recent trials (4)

NCT05348200Lead sponsorPhase 2Apr 22, 2022
NCT05348200Overall official - principal investigatorPhase 2Apr 22, 2022
NCT02689856Study directorPhase 2May 1, 2015
NCT02689856Lead sponsorPhase 2May 1, 2015

Details

Founded: Cranford, NJ, US Jan 1, 2007
Last known activity: Aug 7, 2024